MX9102512A - Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon. - Google Patents

Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon.

Info

Publication number
MX9102512A
MX9102512A MX9102512A MX9102512A MX9102512A MX 9102512 A MX9102512 A MX 9102512A MX 9102512 A MX9102512 A MX 9102512A MX 9102512 A MX9102512 A MX 9102512A MX 9102512 A MX9102512 A MX 9102512A
Authority
MX
Mexico
Prior art keywords
treatment
oral administration
lung diseases
alpha interferon
interferon
Prior art date
Application number
MX9102512A
Other languages
English (en)
Inventor
Roberto J Spiegel
Francis M Cuss
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9102512A publication Critical patent/MX9102512A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
MX9102512A 1990-12-14 1991-12-11 Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon. MX9102512A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62824090A 1990-12-14 1990-12-14

Publications (1)

Publication Number Publication Date
MX9102512A true MX9102512A (es) 1992-06-01

Family

ID=24518070

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9102512A MX9102512A (es) 1990-12-14 1991-12-11 Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon.

Country Status (11)

Country Link
EP (1) EP0563177A1 (es)
JP (1) JPH06503570A (es)
AU (1) AU9139091A (es)
CA (1) CA2098393A1 (es)
EE (1) EE9400337A (es)
IE (1) IE914326A1 (es)
IL (1) IL100332A0 (es)
MX (1) MX9102512A (es)
PT (1) PT99784A (es)
WO (1) WO1992010207A1 (es)
ZA (1) ZA919769B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9213322D0 (en) * 1992-06-23 1992-08-05 Efamol Holdings Antioxidant compositions
ATE205256T1 (de) * 1994-04-09 2001-09-15 Hoffmann La Roche Verfahren zur herstellung von alpha-interferon
CN1151840C (zh) * 1996-05-09 2004-06-02 太平洋制药控股公司 干扰素在制备用于治疗哺乳动物肿瘤病的药剂中的应用
AUPN976596A0 (en) * 1996-05-09 1996-05-30 Pharma Pacific Pty Ltd Stimulation of host defence mechanisms
JP3806445B2 (ja) 1996-05-09 2006-08-09 ファーマ・パシフィック・プロプライエタリー・リミテッド 治療方法
US6207145B1 (en) 1997-05-09 2001-03-27 Pharma Pacific Pty Ltd. Therapeutic applications of high dose interferon
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
AU2002330801A1 (en) * 2002-06-20 2004-01-06 Igor Anatolievich Pomytkin Method for oral transmucosal delivery of interferon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077063B1 (en) * 1981-10-13 1988-03-16 Exovir, Inc. Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
ZA899113B (en) * 1988-12-01 1990-08-29 Schering Corp Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
WO1992010207A1 (en) 1992-06-25
ZA919769B (en) 1992-09-30
IE914326A1 (en) 1992-06-17
CA2098393A1 (en) 1992-06-15
AU9139091A (en) 1992-07-08
EP0563177A1 (en) 1993-10-06
JPH06503570A (ja) 1994-04-21
PT99784A (pt) 1992-12-31
IL100332A0 (en) 1992-09-06
EE9400337A (et) 1996-02-15

Similar Documents

Publication Publication Date Title
NL190832C (nl) Tandbehandelingsmiddel met anti-tandsteenwerking.
IT1057109B (it) Pompa per infusioni impiantabile nel corpo umano
YU79393A (sh) Terapeutska kombinacija
DE69430693D1 (de) Medizinisches Beatmungsgerät
TR25681A (tr) Agiz ici temizlik ve bakimini saglamaya yönelik bilesimler.
DE69206378D1 (de) Patientenliegetische.
IT8648358A0 (it) Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
DK360188A (da) Laegemiddelafgivelsesorgan
DE3771611D1 (de) Butensaeure-n-phenylamide mit pharmazeutischen eigenschaften.
DE3788727T2 (de) Zahnreiniger und dessen herstellung.
DE59009354D1 (de) Zahnärztlicher Patientenstuhl.
IT9048057A0 (it) Impiego di uridina nel trattamento farmacologico delle complicazioni periferiche del diabete.
MX9102512A (es) Administracion oral de interferon alfa en el tratamiento de enfermedades del pulmon.
NO911429D0 (no) Stoffbehandling.
LV12067A (lv) 17B-N-vienaizvietota-karbamoil-4-aza-5alfa-androst-1-en-3-onu pielietojums medikamenta razosanai
NO911430L (no) Stoffbehandlingsmetode.
IT8519042A0 (it) Impiego di chinoloni nel trattamento di malattie cardiache.!
ZW5790A1 (en) Interferon for the use in the prevention or treatment of swine pneumonia or related bacterial diseases
DE3886155D1 (de) Anthracyclin-Derivate mit Inhibitorwirkung gegen die reverse Transkriptase des menschlichen Immundefizienzvirus.
EP0624368A3 (en) Use of a composition to stimulate glutathione synthesis for the manufacture of a medicament for the treatment of AID.
DE69103824T2 (de) Patientenliegetische.
DK692087D0 (da) Peptid med renin-inhibitorisk virkning
IT1224673B (it) Composizione farmaceutica comprendente un analogo di somatostatina esuo impiego nel trattamento del cancro della mammella
MX9201665A (es) Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos.
IT1246296B (it) Procedimento di estrzione e purificazione del gamma interferone umano ricombinante